Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

Haematologica, Vol 92, Issue 2, 279-280 doi:10.3324/haematol.10454
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auwerda, J. J.A.
Right arrow Articles by Leebeek, F. W.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auwerda, J. J.A.
Right arrow Articles by Leebeek, F. W.G.

Multiple Myeloma

Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma

Johannes J.A. Auwerda*,°,, Pieter Sonneveld*, Monica P.M. de Maat*, Frank W.G. Leebeek*

* Department of Haematology, Erasmus University Medical Center, Rotterdam
° Department of Internal Medicine Ikazia Hospital, Rotterdam, the Netherlands

Correspondence: Johannes J.A. Auwerda, MD, Erasmus MC, Dept of Hematology, 3000 CA Rotterdam, PO Box 2040, the Netherlands. Phone: international +31.10.4633740. Fax: internatioal +31.10.4635814. E-mail: jja.auwerda{at}ikazia.nl

Prothrombotic coagulation abnormalities were analyzed in patients with untreated multiple myeloma. Increases in factor VIII, in von Willebrand factor and a decrease in protein S were observed and these changes were strongly associated with disease stage. No difference in baseline coagulation parameters was found between patients with and without subsequent venous thromboembolism.

Key words: newly diagnosed multiple myeloma, coagulation abnormalities, vWF, factor VIII, antiphospholipid antibodies, protein S.




This article has been cited by other articles:


Home page
 BloodHome page
D. C. Johnson, S. Corthals, C. Ramos, A. Hoering, K. Cocks, N. J. Dickens, J. Haessler, H. Goldschmidt, J. A. Child, S. E. Bell, et al.
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
Blood, December 15, 2008; 112(13): 4924 - 4934.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Y. Kristinsson, T. R. Fears, G. Gridley, I. Turesson, U.-H. Mellqvist, M. Bjorkholm, and O. Landgren
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
Blood, November 1, 2008; 112(9): 3582 - 3586.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
C. S. Eby
Bleeding and Thrombosis Risks in Plasma Cell Dyscrasias
Hematology, January 1, 2007; 2007(1): 158 - 164.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2007 by the Ferrata Storti Foundation.